Latest from The Oncologist

The Oncologist is committed to helping physicians excel in the constantly changing fields of oncology and hematology through the publication of timely reviews, original studies, and commentaries on important developments.

May 4, 2021
Relationship of HER2 Alteration and Microsatellite Instability Status in Colorectal Adenocarcinoma

The Oncologist, EarlyView.

May 4, 2021
Efficacy and Safety of Trametinib in Non‐V600 BRAF Mutant Melanoma: A Phase II Study

The Oncologist, EarlyView.

May 4, 2021
Low‐Dose Olanzapine Plus Granisetron and Dexamethasone for Carboplatin‐Induced Nausea and Vomiting in Patients with Thoracic Malignancies: A Prospective Multicenter Phase II Trial

The Oncologist, EarlyView.

May 3, 2021
Salvage Treatment Using Anti–PD‐1/CTLA‐4 Immunotherapy After Failure of Neoadjuvant Chemotherapy in Microsatellite Instable Gastroesophageal Carcinoma

The Oncologist, EarlyView.

April 30, 2021
Safety and Efficacy of First‐Line Pembrolizumab in Black Patients with Metastatic Non‐Small Cell Lung Cancer

The Oncologist, EarlyView.